Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.

Jupiter Endovascular has treated the first two patients in the SPIRARE I study, utilising its Vertex pulmonary embolectomy ...

Robert W. Baird has recently initiated Vertex Inc (VERX) stock to Outperform rating, as announced on July 23, 2024, according to Finviz. Earlier, on March 1, 2024, BofA Securities had raised the stock ...

In this article, we are going to take a look at where Vertex Pharmaceutical Inc. (NASDAQ:VRTX) stands against Jim Cramer's other go-to stocks for success. In a recent episode of Mad Money ...

Most investors are happy if a stock doubles within four or five years. Vertex Pharmaceuticals (NASDAQ: VRTX) shareholders should be ecstatic. Its share price has skyrocketed 140% over the last ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Timothy Li is a consultant, accountant, and finance manager with an MBA from USC and over 15 years of ...

Your mission: decipher the values assigned to each object and solve the final equation. The Twist: You have only 19 seconds to find the solution to this puzzle. Don't panic, math wizards!